A Historical Controlled, Single Center Open Label Pilot Study Comparing the Effectiveness and Tolerability of De Novo Initiation of Letermovir versus Valganciclovir for Cytomegalovirus Prophylaxis in African American Kidney Transplant Recipients

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

Prevymis (letermovir) - Merck (MSD)

I. Yakubu; G. Abebe; D. Kumar; A. Brown; I. Moinuddin; M. Morales; S. Sterling; A. Iaria; B. Agegnehu; R. Marks; M. Saeed; G. Gupta

Jul 30, 2025